B.Pharm

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Analyst

The Regional Ayurveda Research Institute for Metabolic Disorders, Bangalore, a peripheral Institute of Central Council for Research in Ayurvedic Sciences, an autonomous body under the Ministry of AYUSH, Govt, of India.

Post : Pharmacist

1mg is India’s leading consumer health platform with over 3 Million downloads. It aspires to be the trusted health partner for all Indians and its mission is to make healthcare accessible, understandable and affordable for a billion Indians. It enables consumers to learn more about their medicines and also find more cost-effective substitutes. 1mg’s doctor platform aims to revolutionize how a consumer finds the right healthcare professional for his needs. It’s recently launched diagnostics service brings transparency and price-effectiveness to lab tests. 1mg is an initiative taken in the spirit of public service with a vision to empower Indian consumers and caregivers to select the most appropriate healthcare service at the best possible price.

Post: Pharmacist

Apotex is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. We are the 7th largest generic pharmaceutical company globally with more than 12,000 employees and estimated sales of approximately $3 billion. Our fully integrated operation is comprised of four lines of business: Global Generics; Apobiologix; Global Active Pharmaceutical Ingredients (API); and ApoPharma (Innovative Products). With our worldwide manufacturing sites, Apotex can produce up to 24 billion dosages per year. We produce 300 medicines in 4,000 dosages and formats that are exported to 115 countries. Apotex will spend $2 billion over the next 10 years on research and development.

Post : Associate / Sr. Associate - Global Pharmacovigilance

Roche Pharmaceuticals, India, has been disseminating scientific knowledge pertaining to innovative medicines to the medical fraternity. We have products in therapeutic areas such as Oncology, Virology, Nephrology, Transplantation, Anemia and Rheumatoid Arthritis. In recognition of its contributions in Oncology, Roche India has been awarded the Best Oncology Company of the Year, by Frost & Sullivan at the India Healthcare Excellence Awards for the years 2011, 2012 and 2014.

Post : Value Specialist

ABOUT AUTHOR
DR. PRANJAL BORDOLOI
VP – PHARMACOLGY & COD
VEEDA CLINICAL RESEARCH PVT LTD.
info@veedacr.com

Therapeutic innovation in cancer treatment has always been in focus. Based on WHO data, worldwide, there were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 million people living with cancer within 5 years of diagnosis by year 2012. Top 5 most frequent cancers in world (ranked by number of new cases) are breast, prostate, lung, colorectal, and cervical cancers per 2012 WHO data (International Agency for Research on Cancer, WHO). For countries like India, the top 5 most frequent cancers (ranked by number of new cases) are breast, cervical, oral cavity, lung and colorectal cancers (International Agency for Research on Cancer, WHO). Reported age-adjusted incidence rates for cancer are still quite low in the demographically young country. Little more than 1 million new cases of cancer are diagnosed every year in India. An estimated 600 000–700 000 deaths in India were caused by cancer in 2012. In age-standardized terms this is close to the mortality burden seen in high-income countries. Such figures are somewhat indicative of low rates of early-stage detection and poor treatment outcomes (Mallath MK, et al. 2014).

PERD Bio-incubator invites applications from students / young faculty members /  research scholars and other interested people in pharma, Biotech, life science, health care and allied science sector who wishes to start a new business based on innovative ideas & are having solutions to the existing problems in society. The interested applicant can be at
1. Ideation stage
2. Proof of concept stage
3. Scaling up stage
4. Marketing and business development stage

PERD Bio-incubator provides hand-holding at all stages of entrepreneurial development and also helps for getting funds from various Govt. schemes and investors.

Objectives

• To support innovators to become entrepreneur
• To provide easy entry and exit from the in the scheme
• To provide networking support to startups
• To provide a research ambience and expert services
• To support innovators and startups with skilled human resources

For more details about the incubator and for the application format please visit : http://perdcentre.com/BIRAC.html
or contact us on email at : perd@perdcentre.com, neetas@perdcentre.com
or on phone at : +917927439375

Applications are invited from the eligible candidates of District Pulwama for below posts, as per the criteria shown against each.

National Agri-Food Biotechnology Institute (NABI) is an autonomous Institute under Department of Biotechnology, Government of India. NABI aims at catalysing the transformation of Agri-food sector in India by being a nodal organization for knowledge generation and translational science leading to value-added products based on Agri-Food biotech innovations for improved household nutritional security. Since its inception in 2010, NABI is involved in research activities for the Bio fortification, development of designer crops for improved nutrition, providing sustainable and novel solutions towards quality food and nutrition, and development of evidence based functional foods to counter malnutrition. Food and nutritional Biotechnology division at NABI requires following research personnel purely on temporary basis.